The urgent need for proper information and Prevention for prostate cancer The Hellenic Urological Society (EEA) points out, on the occasion of the European Day against Prostate Cancer on September 15th. He recalls that prostate cancer is one of the most common malignancies in men worldwide and invites every man to be informed responsibly about early detection and modern diagnostic tools.

In Europe, every year, About 450,000 men are diagnosed with prostate cancer overcoming colon cancer. Every year 107,000 European men die of prostate cancer. In the European Union, prostate cancer was the third most commonly diagnosed cancer, representing 12.1% of new cancers in 2022. In total, about 2.7 million new cancer diagnoses of all types and about 1.3 million deaths were recorded in the EU. Exact evidence shows that prostate cancer kills more men than breast cancer kills women.

In Greece, In 2022 there were 7,036 new prostate incidents ranking him first in frequency in men (19.2% of new cases). The latest available data indicate that 27,358 people live with a diagnosis of prostate cancer within five years while Mortality touches about 2,000 people.

With these data, the President of the Hellenic Urological Society, Andreas Skolarikoshe emphasizes: “Prostate cancer is a major issue of public health. The Hellenic Urological Society reaffirms its commitment to documented, personalized, early detection and equal access to patients in modern diagnosis and treatment. We invite every man to consult his urologist and families in time to support prevention. Information saves lives. “

Today, it is the most often diagnosed cancer in men in 112 of 185 countries, and the leading cause of cancer death between men in 48 countries, an element that highlights international inequalities in early diagnosis and care. According to the World Cancer Observatory (Global Cancer Observatory 2022), the prostate is the second most common malignancy in men after the lung. Mortality reaches almost 400,000 people in 2022, with over 5 million living with a five -year diagnosis, evidence that prostate cancer remains a significant cause of morbidity and mortality worldwide.

In a depth of 15 years, Lancet (2024) Analysis (2024) on prostate cancer report that by 2040 there will be almost 3 million new prostate cancer diagnoses each year worldwide (ie about 2.9 million), while the annual mortality is expected to increase by approximately 85%, approximately 85%of the annual mortality. disproportionate burden for low and medium -income countries.

As the Hellenic Urological Society notes, from diagnosis to treatment, artificial intelligence is increasingly important as a complementary tool in the hands of science. “In the field of diagnosis, artificial intelligence has the power to recognize pattern recognition within complex medical data, improving decision making. Either by guiding during surgery or creating three -dimensional models of multiparametric magnetic resonance imaging (Multiparametric MRI) up to 3D printing personalized for each patient who help the surgeon before surgery. Her contribution is decisive, ”says Prokar Dasgupta.

These data highlights the value of the method in patient preventive control and the need for early and effective diagnosis, as in the early stages of the disease prostate cancer is practically curable, according to the Hellenic Urological Society.